Home / IRIX : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does IRIX make money? Does IRIX have pricing power? What's the Earnings Whisper? Will IRIX profit more as the business scales? What is IRIX's management track record? Is IRIX's current price justified?

IRIDEX Corporation

$0.64 -$0.53 (-45.30%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$0.66

Day Range

$0.62$0.66

Year Range

$0.62$1.65

Market Cap

11.08M

AVG Volume

67.58K

Trailing/Forward PE

-3.15/32

PEG ratio

0.03

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

NASDAQ

Revenue (USD)

IRIX Revenue (USD) by year
Period	Revenue (USD)
2025	52.67M
2024	48.67M
2023	51.87M
2022	56.97M
2021	53.9M
2020	36.35M
2019	43.45M
2018	42.6M
2017	41.59M
2016	46.16M

Net Income (USD)

IRIX Net Income (USD) by year
Period	Net Income (USD)
2025	-4.44M
2024	-8.91M
2023	-9.57M
2022	-7.55M
2021	-5.22M
2020	-6.33M
2019	-8.81M
2018	-12.81M
2017	-12.87M
2016	-11.71M

Operating Income (USD)

IRIX Operating Income (USD) by year
Period	Operating Income (USD)
2025	-2.57M
2024	-8.3M
2023	-10.01M
2022	-7.54M
2021	-7.53M
2020	-6.58M
2019	-8.97M
2018	-12.87M
2017	-12.89M
2016	-2.56M

EBITDA (USD)

IRIX EBITDA (USD) by year
Period	EBITDA (USD)
2025	-2.83M
2024	-7.42M
2023	-7.45M
2022	-5.57M
2021	-4.22M
2020	-6.08M
2019	-8.28M
2018	-12.06M
2017	-12.17M
2016	-1.8M

Cash Flows (USD)

IRIX Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-2.18M
2024	-7.3M
2023	-6.85M
2022	-9.8M
2021	8M
2020	-3.33M
2019	-8.04M
2018	-10.46M
2017	-4.14M
2016	-1.21M

EPS (USD)

IRIX EPS (USD) by year
Period	EPS (USD)
2025	-0.26
2024	-0.54
2023	-0.59
2022	-0.47
2021	-0.34
2020	-0.45
2019	-0.64
2018	-1.06
2017	-1.11
2016	-1.13

Expenses (USD)

IRIX Expenses (USD) by year
Period	Expenses (USD)
2025	21.86M
2024	27.82M
2023	31.92M
2022	33.2M
2021	30.58M
2020	22.24M
2019	27.04M
2018	30.78M
2017	29.11M
2016	24.35M

Cash & Debt (USD)

IRIX Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	6.03M
2024	2.39M
2023	7.03M
2022	13.92M
2021	23.85M
2020	11.63M
2019	12.65M
2018	21.19M
2017	21.71M
2016	23.75M

Debt ratios

IRIX Debt ratios by year
Period	Debt ratios
2025	0.06
2024	-0.09
2023	0.18
2022	0.5
2021	0.69
2020	0.19
2019	0.28
2018	0.84

Margins

IRIX Margins by year
Period	Margins
2025	36.65%
2024	39.9%
2023	41.88%
2022	44.53%
2021	42.36%
2020	42.8%
2019	41.29%
2018	41.01%
2017	37.27%
2016	45.15%

Return on Capital

IRIX Return on Capital by year
Period	Return on Capital
2025	-90.15%
2024	-424.89%
2023	-100.5%
2022	-43.8%
2021	-22.43%
2020	-36.44%
2019	-38.82%
2018	-42.77%
2017	-42.16%
2016	-29.91%

Shares Outstanding

IRIX Shares Outstanding by year
Period	Shares Outstanding
2025	17.19M
2024	16.64M
2023	16.25M
2022	15.99M
2021	15.54M
2020	13.9M
2019	13.78M
2018	13.6M
2017	11.59M
2016	10.44M

Book Value Per Share (USD)

IRIX Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	0.29
2024	0.13
2023	0.59
2022	1.08
2021	1.5
2020	1.25
2019	1.65
2018	2.2
2017	2.63
2016	3.75

Total Assets (USD)

IRIX Total Assets (USD) by year
Period	Total Assets (USD)
2025	29.15M
2024	29.14M
2023	34.44M
2022	42.29M
2021	48.69M
2020	27.97M
2019	34.81M
2018	41.67M
2017	41.65M
2016	48.14M

Employee Count

IRIX Employee Count by year
Period	Employee Count
2026	93
2024	93
2023	111
2022	130
2022	119
2021	89
2019	11
2018	17
2017	38
2016	121

Free Cash Flow Yield

IRIX Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-15.89%
Sep 26	-15.41%
Sep 26	-14.53%
Aug 26	-14.39%
Aug 26	-13.45%
Aug 26	-16.55%
Aug 26	-17.06%
Jul 26	-17.27%
Jul 26	-15.9%
Jul 26	-15.16%
Jul 26	-12.88%
Jul 26	-12.53%
Jun 26	-12.53%
Jun 26	-12.53%
Jun 26	-12.65%
Jun 26	-12.99%
May 26	-13.49%
May 26	-14.02%
May 26	-12.54%
May 26	-12.29%
May 26	-12.29%
Apr 26	-11.94%
Apr 26	-11.94%
Apr 26	-12.66%
Apr 26	-12.92%
Mar 26	-23.68%
Mar 26	-17.37%
Mar 26	-18.04%
Mar 26	-18.91%
Feb 26	-16.75%
Feb 26	-16.87%
Feb 26	-16.99%
Feb 26	-16.06%
Jan 26	-15.74%
Jan 26	-15.43%
Jan 26	-16.63%
Jan 26	-20.39%
Jan 26	-20.04%
Dec 25	-19.06%
Dec 25	-23.45%
Dec 25	-25.46%
Dec 25	-24.94%
Nov 25	-24.42%
Nov 25	-25.21%
Nov 25	-23.92%
Nov 25	-33.09%
Oct 25	-33.41%
Oct 25	-31.89%
Oct 25	-33.73%
Oct 25	-33.73%
Oct 25	-29.23%
Sep 25	-30.5%
Sep 25	-29.48%
Sep 25	-26.58%
Sep 25	-25.06%
Aug 25	-26.18%
Aug 25	-28.29%
Aug 25	-31.04%
Aug 25	-31.3%
Aug 25	-31.79%
Jul 25	-28.86%
Jul 25	-32.3%
Jul 25	-40.29%
Jul 25	-43.76%
Jun 25	-46.24%
Jun 25	-43.62%
Jun 25	-43.29%
Jun 25	-41.82%
May 25	-40.78%
May 25	-41.53%
May 25	-40.29%
May 25	-38.15%
May 25	-36.86%
Apr 25	-35.96%
Apr 25	-43.01%
Apr 25	-46.55%
Apr 25	-50.9%
Mar 25	-43.91%
Mar 25	-42.63%
Mar 25	-37.35%
Mar 25	-33.5%
Feb 25	-30.58%
Feb 25	-27.95%
Feb 25	-27.23%
Feb 25	-26.21%
Jan 25	-25.73%
Jan 25	-25.73%
Jan 25	-25.42%
Jan 25	-25.58%
Jan 25	-23.84%
Dec 24	-25.27%
Dec 24	-25.73%
Dec 24	-24.54%
Dec 24	-23.58%
Nov 24	-23.58%
Nov 24	-23.45%
Nov 24	-24.97%
Nov 24	-25.57%
Nov 24	-23.69%
Oct 24	-23.38%

Price to Sales

IRIX Price to Sales by year
Period	Price to Sales
Sep 26	0.22
Sep 26	0.22
Sep 26	0.24
Aug 26	0.24
Aug 26	0.25
Aug 26	0.28
Aug 26	0.27
Jul 26	0.27
Jul 26	0.29
Jul 26	0.31
Jul 26	0.36
Jul 26	0.37
Jun 26	0.37
Jun 26	0.37
Jun 26	0.37
Jun 26	0.36
May 26	0.35
May 26	0.33
May 26	0.33
May 26	0.34
May 26	0.34
Apr 26	0.35
Apr 26	0.35
Apr 26	0.33
Apr 26	0.32
Mar 26	0.33
Mar 26	0.45
Mar 26	0.44
Mar 26	0.42
Feb 26	0.47
Feb 26	0.47
Feb 26	0.46
Feb 26	0.49
Jan 26	0.5
Jan 26	0.51
Jan 26	0.47
Jan 26	0.39
Jan 26	0.39
Dec 25	0.41
Dec 25	0.34
Dec 25	0.31
Dec 25	0.32
Nov 25	0.32
Nov 25	0.31
Nov 25	0.33
Nov 25	0.36
Oct 25	0.35
Oct 25	0.37
Oct 25	0.35
Oct 25	0.35
Oct 25	0.41
Sep 25	0.39
Sep 25	0.4
Sep 25	0.45
Sep 25	0.47
Aug 25	0.45
Aug 25	0.42
Aug 25	0.38
Aug 25	0.45
Aug 25	0.44
Jul 25	0.48
Jul 25	0.43
Jul 25	0.35
Jul 25	0.32
Jun 25	0.3
Jun 25	0.32
Jun 25	0.32
Jun 25	0.33
May 25	0.34
May 25	0.34
May 25	0.35
May 25	0.39
May 25	0.41
Apr 25	0.42
Apr 25	0.35
Apr 25	0.32
Apr 25	0.29
Mar 25	0.34
Mar 25	0.34
Mar 25	0.39
Mar 25	0.43
Feb 25	0.47
Feb 25	0.52
Feb 25	0.53
Feb 25	0.55
Jan 25	0.56
Jan 25	0.56
Jan 25	0.57
Jan 25	0.56
Jan 25	0.61
Dec 24	0.57
Dec 24	0.56
Dec 24	0.59
Dec 24	0.61
Nov 24	0.61
Nov 24	0.62
Nov 24	0.58
Nov 24	0.46
Nov 24	0.49
Oct 24	0.5

Price/Operating Cashflow

IRIX Price/Operating Cashflow by year
Period	Price/Operating Cashflow
May 22	6.54
Apr 22	7.24
Apr 22	7.7
Apr 22	8.21
Apr 22	8.19
Apr 22	8.81
Mar 22	8.36
Mar 22	8.74
Mar 22	6.5
Mar 22	6.9
Feb 22	7.01
Feb 22	7.36
Feb 22	7.76
Feb 22	8.12
Jan 22	8.09
Jan 22	8.03
Jan 22	8.85
Jan 22	9.15
Dec 21	9.69
Dec 21	9.87
Dec 21	9.2
Dec 21	10
Dec 21	9.44
Nov 21	10.34
Nov 21	12.12
Nov 21	12.76
Nov 21	13.57
Oct 21	11.11
Oct 21	10.94
Oct 21	10.73
Oct 21	11.49
Oct 21	10.88
Sep 21	10.85
Sep 21	10.44
Sep 21	10.52
Sep 21	10.29
Aug 21	10.94
Aug 21	11.01
Aug 21	11.56
Aug 21	9.4
Jul 21	9.34
Jul 21	9.41
Jul 21	8.98
Jul 21	9.45
Jul 21	10.17
Jun 21	10.57
Jun 21	10
Jun 21	11.05
Jun 21	10.85
May 21	11.22
May 21	11
May 21	10.7

Price to Book

IRIX Price to Book by year
Period	Price to Book
Sep 26	3.06
Sep 26	3.15
Sep 26	3.34
Aug 26	3.37
Aug 26	3.61
Aug 26	3.13
Aug 26	3.04
Jul 26	3
Jul 26	3.26
Jul 26	3.42
Jul 26	4.02
Jul 26	4.13
Jun 26	4.13
Jun 26	4.13
Jun 26	4.1
Jun 26	3.99
May 26	3.84
May 26	3.69
May 26	3.53
May 26	3.6
May 26	3.6
Apr 26	3.7
Apr 26	3.7
Apr 26	3.49
Apr 26	3.42
Mar 26	3.6
Mar 26	4.91
Mar 26	4.72
Mar 26	4.51
Feb 26	5.09
Feb 26	5.05
Feb 26	5.01
Feb 26	5.31
Jan 26	5.41
Jan 26	5.52
Jan 26	5.12
Jan 26	4.18
Jan 26	4.25
Dec 25	4.47
Dec 25	3.63
Dec 25	3.35
Dec 25	3.42
Nov 25	3.49
Nov 25	3.38
Nov 25	3.56
Nov 25	2.94
Oct 25	2.91
Oct 25	3.05
Oct 25	2.88
Oct 25	2.88
Oct 25	3.33
Sep 25	3.19
Sep 25	3.3
Sep 25	3.66
Sep 25	3.88
Aug 25	3.71
Aug 25	3.44
Aug 25	3.13
Aug 25	25.52
Aug 25	25.13
Jul 25	27.68
Jul 25	24.74
Jul 25	19.83
Jul 25	18.26
Jun 25	17.28
Jun 25	18.32
Jun 25	18.46
Jun 25	19.11
May 25	19.59
May 25	19.24
May 25	19.83
May 25	9.12
May 25	9.44
Apr 25	9.68
Apr 25	8.09
Apr 25	7.48
Apr 25	6.84
Mar 25	7.93
Mar 25	6.26
Mar 25	7.14
Mar 25	7.96
Feb 25	8.72
Feb 25	9.55
Feb 25	9.8
Feb 25	10.18
Jan 25	10.37
Jan 25	10.37
Jan 25	10.49
Jan 25	10.43
Jan 25	11.19
Dec 24	10.56
Dec 24	10.37
Dec 24	10.87
Dec 24	11.32
Nov 24	11.32
Nov 24	11.38
Nov 24	10.68
Nov 24	5.33
Nov 24	5.75
Oct 24	5.83

No video analysis for this stock yet. Request one from our team.

News: IRIX

zacks.com · 25 Aug 2026

IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%

IRIX's Q2 loss per share widens year over year and revenues decline as Middle East disruptions and reduced sell-through in China weigh on retina sales, offsetting continued growth in the Cyclo G6 product family.

seekingalpha.com · 18 Aug 2026

IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript

globenewswire.com · 18 Aug 2026

Iridex Reports Second Quarter 2026 Financial Results

MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today reported financial results for the second quarter ended July 4, 2026.

globenewswire.com · 4 Aug 2026

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the second quarter 2026 and provide a business update after the close of trading on August 18, 2026.

globenewswire.com · 20 Jul 2026

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced the expansion of its EyeProGPO product offering to include the Company's line of EndoProbe® Handpieces.